Could a new approach to prevention create a healthier and more resilient Britain? Today, Pfizer has launched ‘VacciNation’ - a vision for protecting the health, wealth and resilience of the UK by unlocking the personal and societal value of vaccines at every stage of life.
VacciNation sets out a series of thought-provoking ideas to address systemic challenges in the use of, and access to, life-changing and life-saving vaccines, while cementing the UK’s position at the forefront of research and innovation.
These ideas are focused on achieving three priorities:
- Maximising the value that vaccination can deliver to the nation’s health and the UK economy
- Unleashing the potential of vaccination across society to tackle major health challenges, regardless of age
- Making vaccination a priority across the NHS
The UK has a long-standing and proud heritage in vaccine development. VacciNation highlights the potential to build on this legacy and secure the UK’s position as a global leader in preventative healthcare well into the future.
Many major health economies prioritise investment in medicines and cures to treat ill health over keeping people well. Today in the UK, we spend £97 billion a year on treating diseases and only £8 billion on preventing them.1 VacciNation calls for a rebalance, allowing us to better understand the longer-term and lifelong benefits of vaccination in maintaining population health and reducing health inequalities, as well as realising significant economic value.2
VacciNation also highlights the potential for the NHS to make vaccination a priority. One of the opportunities is to put adult vaccinations on a par with childhood vaccinations, helping us better meet the demands of a growing and ageing population, and protecting some of the most vulnerable from disease.
With the release of VacciNation today, Pfizer is looking to build strong, collaborative partnerships to support the UK in tackling the challenges faced by the NHS and to deliver a new generation of innovative vaccines to support health throughout life.
VacciNation: a vision for UK immunisation
- DHSC. Prevention is better than cure: Our vision to help you live well for longer. Accessed Nov 2021
- Quilici S, Smith R, et al. Role of vaccination in economic growth. Accessed Nov 2021
- ABPI. Vaccines. Accessed Nov 2021
- WHO. Vaccine safety and false contraindications to vaccination. Accessed Nov 2021
- WHO. Vaccination greatly reduces disease, disability, death and inequity worldwide. Accessed Nov 2021
- Public Health England. Pneumococcal Polysaccharide Vaccine (PPV) coverage report, England, April 2019 to March 2020. Accessed Nov 2021
- Public Health England. Shingles (quarter 3) vaccine coverage report (adults eligible from April to December 2019 and vaccinated to end-March 2020) in England. Accessed Nov 2021
PP-PFE-GBR-4224 / November 2021